Последнее обновление :
03/05/2024
Стимулятор дыхания   Caffeine citrate  
Инъекция
Раствор для перорального приёма
Стабильность растворов Стабильность смесей Факторы, которые влияют на стабильность Совместимость Способы введения Библиография Pdf
   Химическая структура  

Товарное название   Товарное название     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cafcit Соединённые Штаты Америки
Cafeina 25% Bioquim Аргентина
Cafeina citrato Испания
Cafeina Fada Аргентина
Cafeine citrate Biomed новая Зеландия
Cafeine Sterop Бельгия
Cafeinnova Колумбия
Caffeinospire Египет
Cafirate Индия
Citrate de caféine Cooper Франция
Peyona oral y para perfusion Испания
Peyona oral/parenteral Германия, Румыния, Турция
Библиография   Инъекция   Библиография : Caffeine citrate  
тип публикация
43 Журнал Fraser BD, Berod T, Whitney HAK.
Stability of caffeine citrate injection in polypropylene syringes at room temperature.
Am J Health-Syst Pharm 1997 ; 54: 1106-1108.
318 Журнал Donnelly RF, Tirona RG.
Stability of citrated caffeine injectable solution in glass vials.
Am J Hosp Pharm 1994 ; 51: 512-514.
691 Журнал Nahata MC, Zingarelli JR, Durell DE.
Stability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutions.
J Clin Pharm Ther 1989 ; 14: 53-55.
1802 Журнал Bell MS, Nolt DH.
Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
Am J Health-Syst Pharm 2003 ; 60: 193-194.
2087 Журнал Ferreira E, Forest JM, Hildgen P.
Compatibility of dimenhydrinate injectable by Y administration.
Pharmactuel 2004 ; 37: 17-20.
3379 Журнал Fox L.M, Wilder A.G, Foushee J.A.
Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
Am J Health-Syst Pharm 2013 ;70:520-524.
3644 Лаборатория Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3976 Журнал Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
4319 Журнал Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4389 Журнал Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4419 Журнал Holt R.J, Siegert S.W.K, Krishna A.
Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
J Pediatr Pharmacol Ther 2008 ; 13, 3: 155-161.
4543 Журнал Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4603 Журнал Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Hosp Pharm 2021 ; 56, 4: 228-234.
4742 Журнал Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.

  Mentions Légales